Document is current
Any future updates will be listed below
-
Authors
Armstrong, April W.
Foster, Shonda A.
Comer, Brian S.
Lin, Chen-Yen
Malatestinic, William
Burge, Russel
Goldblum, Orin
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 27 March 2018
Accepted: 11 June 2018
First Online: 28 June 2018
Ethics approval and consent to participate
: Research using de-identified records was reviewed and approved by the New England Independent Review Board.
: Not applicable.
: A.W. Armstrong: Investigator and/or consultant to Amgen, AbbVie, Janssen, Eli Lilly, Novartis, Valeant, Regeneron, Sanofi, and Modernizing Medicine.S. A. Foster, B. S. Comer, C-Y. Len, W. Malatestinic, R. Burge, and O. Goldblum: All employees and stockholders of Eli Lilly and Company.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
